337 related articles for article (PubMed ID: 37081781)
61. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
62. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
Song J; Su ZZ; Shen QM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
[TBL] [Abstract][Full Text] [Related]
63. Overexpression of LINC00261 inhibits non-small cell lung cancer cells progression by interacting with miR-522-3p and suppressing Wnt signaling.
Shi J; Ma H; Wang H; Zhu W; Jiang S; Dou R; Yan B
J Cell Biochem; 2019 Oct; 120(10):18378-18387. PubMed ID: 31190356
[TBL] [Abstract][Full Text] [Related]
64. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
[TBL] [Abstract][Full Text] [Related]
65. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
[TBL] [Abstract][Full Text] [Related]
66. circFBXO7/miR-96-5p/MTSS1 axis is an important regulator in the Wnt signaling pathway in ovarian cancer.
Wu M; Qiu Q; Zhou Q; Li J; Yang J; Zheng C; Luo A; Li X; Zhang H; Cheng X; Lu W; Liu P; Lu B; Lu Y
Mol Cancer; 2022 Jun; 21(1):137. PubMed ID: 35768865
[TBL] [Abstract][Full Text] [Related]
67. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.
Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y
Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699
[TBL] [Abstract][Full Text] [Related]
68. Higher expression of miR-150-5p promotes tumorigenesis by suppressing LKB1 in non-small cell lung cancer.
Wu Z; Li W; Li J; Zhang Y; Zhang X; Xu Y; Hu Y; Li Q; Sun Q; Ma Z
Pathol Res Pract; 2020 Nov; 216(11):153145. PubMed ID: 32827803
[TBL] [Abstract][Full Text] [Related]
69. MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway.
Wang X; Zhao H; Wang P; Zhang J; Li N; Liu Y; Zhang F; Yu Y
Anticancer Drugs; 2022 Nov; 33(10):989-998. PubMed ID: 36206129
[TBL] [Abstract][Full Text] [Related]
70. LINC00942 Promotes Tumor Proliferation and Metastasis in Lung Adenocarcinoma via FZD1 Upregulation.
Wang R; Wang X; Zhang J; Liu Y
Technol Cancer Res Treat; 2021; 20():1533033820977526. PubMed ID: 34253104
[TBL] [Abstract][Full Text] [Related]
71. Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis.
Xia H; Niu Q; Ding Y; Zhang Z; Yuan J; Jin W
J Mol Histol; 2021 Aug; 52(4):729-740. PubMed ID: 34050851
[TBL] [Abstract][Full Text] [Related]
72. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
[TBL] [Abstract][Full Text] [Related]
73. MicroRNA-34c-5p Reduces Malignant Properties of Lung Cancer Cells through Regulation of TBL1XR1/Wnt/β-catenin Signaling.
Lai W; Yue Y; Zeng G
Curr Mol Med; 2024; 24(1):114-122. PubMed ID: 36999182
[TBL] [Abstract][Full Text] [Related]
74. Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.
Zhou J; Xiao D; Qiu T; Li J; Liu Z
Technol Cancer Res Treat; 2020; 19():1533033820977525. PubMed ID: 33280517
[TBL] [Abstract][Full Text] [Related]
75. CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.
Li Y; Zhang J; Pan S; Zhou J; Diao X; Liu S
Thorac Cancer; 2020 Mar; 11(3):537-548. PubMed ID: 31917898
[TBL] [Abstract][Full Text] [Related]
76. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
77. Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer.
Wang RQ; Long XR; Zhou NN; Chen DN; Zhang MY; Wen ZS; Zhang LJ; He FZ; Zhou ZL; Mai SJ; Wang HY
J Exp Clin Cancer Res; 2021 Jan; 40(1):9. PubMed ID: 33407724
[TBL] [Abstract][Full Text] [Related]
78. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
Wang Y; Mei X; Song W; Wang C; Qiu X
BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
[TBL] [Abstract][Full Text] [Related]
79. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
[TBL] [Abstract][Full Text] [Related]
80. LINC00852 is associated with poor prognosis in non-small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa-miR-145-5p/KLF4 axis.
Tuo Z; Liang L; Zhou R
J Gene Med; 2021 Dec; 23(12):e3384. PubMed ID: 34342374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
